Syndax Pharmaceuticals, Inc. (SNDX) — Analyst estimates
Consensus analyst estimates for Syndax Pharmaceuticals, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 108.97M | -0.37 | 6 |
| 2027 | 64.86M | -0.16 | 6 |
| 2028 | 684.79M | 0.58 | 8 |
| 2029 | 904.12M | 2.14 | 6 |
| 2030 | 1.10B | 3.12 | 6 |
Consensus analyst estimates by fiscal year.